Riskpilot← Back to searchSign inGet full accessÖrbydoktorn AB
ABActiveOrg 5567761845Gamla Huddingevägen 443Medical specialists activities · NACE 8622Est. 20091 employees
Revenue 2025
SEK 486K
-14% vs 2024
EBITDA margin
45.4%
-26% vs 2024
Equity ratio
81.1%
Financial strength
Net profit 2025
SEK 229K
-19% vs 2024
| Revenue | SEK 486K | -14% |
| EBITDA | SEK 221K | -26% |
| Net profit | SEK 229K | -19% |
| Total assets | SEK 3,3M | +0% |
| Equity | SEK 2,7M | +1% |
| Employees | 1 | — |
Legal name
Örbydoktorn AB
Org number
5567761845
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 januari 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkarvård, undervisning, forskning inom äldrevården samt handel och förvaltning av värdepapper och därmed förenlig verksamhet.
Address
Gamla Huddingevägen 443
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 225 | 3 380 | 1 701 | 566 | 486 |
| Staff expenses | — | — | — | — | −14 |
| EBITDA | 1 258 | 1 038 | −32 | 297 | 221 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 1 258 | 1 038 | −32 | 297 | 221 |
| Net financials | 32 | 51 | 34 | 61 | 71 |
| Profit before tax | 967 | 814 | 12 | 358 | 292 |
| Tax | −207 | −174 | −9 | −76 | −63 |
| Net profit | 760 | 640 | 3 | 282 | 229 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 142 | 3 434 | 3 208 | 3 311 | 3 309 |
| Equity | 2 729 | 2 769 | 2 572 | 2 655 | 2 683 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 90 | 68 | 48 | 68 | 38 |
| Total debt | 90 | 68 | 48 | 68 | 38 |
EBITDA margin
45.4%
This company
15.8%
Market median
+187% vs market
20212025
Equity ratio
81.1%
This company
38.2%
Market median
+112% vs market
20212025
Return on equity
8.5%
This company
18.4%
Market median
-54% vs market
20212025
Net profit margin
47.1%
This company
8.1%
Market median
+481% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BL | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Örbydoktorn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Lennart Samuelsson | Audit | 0 companies |
| Niklas Peter Lindberg | Board of Directors | 0 companies |
| Jan Anders Lindberg | Chairman | 0 companies |
| Maria Alexandra Lindberg | Deputy Board Member | 0 companies |